Digestive Health

Latest News

FDA Grants Expanded Interchangeability Designation to Yuflyma
FDA Grants Expanded Interchangeability Designation to Yuflyma

May 23rd 2025

Adalimumab-aaty (Yuflyma) prefilled syringes and autoinjectors are now fully interchangeable with the reference product adalimumab (Humira) across marketed dosage forms and strengths.

FDA Grants Interchangeability Designation to Ustekinumab-Aauz for Stelara
FDA Grants Interchangeability Designation to Ustekinumab-Aauz for Stelara

May 22nd 2025

Tremfya Demonstrates Sustained Response Up to 92 Weeks
Tremfya Demonstrates Sustained Response Up to 92 Weeks

May 8th 2025

FDA Grants Ustekinumab-Aekn Interchangeability Designation for Stelara
FDA Grants Ustekinumab-Aekn Interchangeability Designation for Stelara

May 7th 2025

Younger Recommended Screening Age Can Lessen Colorectal Cancer Burden
Younger Recommended Screening Age Can Lessen Colorectal Cancer Burden

March 11th 2025

Latest CME Events & Activities

PBM Challenges and the Evolving Role of Oncology Pharmacists in Community Practices

April 30, 2025 | 11:15 AM ET

View More

Strategies for Integrating Biologic Therapy Into the Management of Eosinophilic Esophagitis

1.5 Credits / Immunology, Gastroenterology

View More

Innovations in Inflammatory Bowel Disease Therapy: How IL-23 Inhibitors Are Shaping Treatment and Managed Care...

May 20, 2025 | 1:00 PM and 8:00 PM ET

View More

Navigating Next-Generation Therapies for the Management of Acid-Related Disorders

1.5 Credits / Gastroenterology

View More

Biologic Therapy for the Management of Eosinophilic Esophagitis in Children: The Evolving Treatment Paradigm

1.5 Credits / Gastroenterology, Immunology

View More

The Impact of Pharmacists and Pharmacy Technicians in Recognizing and Responding to Human Trafficking (Pharmac...

2.0 Credits / Human Trafficking, Law

View More

Foundations in the Management of Eosinophilic Esophagitis: Pathophysiology, Clinical, Economic, and Quality of...

1.0 Credit / Gastroenterology, Immunology

View More

Managed Care Insights on the Advances in the Eosinophilic Esophagitis Treatment Landscape

1.0 Credit / Gastroenterology, Immunology, Rare Diseases

View More

The Evolving Treatment Paradigm for the Management of Eosinophilic Esophagitis and the Future of Oral Therapie...

1.0 Credit / Gastroenterology, Immunology

View More

The Role of the Community Pharmacist in the Management of Eosinophilic Esophagitis

1.0 Credit / Gastroenterology, Immunology

View More

Ensuring Pharmacy Technicians’ Proficiency in Risk Evaluation and Mitigation Strategies

1.0 Credit / Law, Pain Management, Opioids

View More

Optimizing Treatment Strategies: A Comprehensive Approach to Primary Biliary Cholangitis and Pruritus

1.5 Credits / Hematologic Cancer, Hematology, Oncology

View More

More News

© 2025 MJH Life Sciences

All rights reserved.